Brazilian consensus on the diagnosis and treatment of extremities soft tissue sarcomas.
Autor: | Spencer RMSSB; Department of Directory, Brazilian Society of Surgical Oncology (BSSO), Rio de Janeiro, Brazil., de Camargo VP; Department of Directory, Brazilian Society of Clinical Surgical (BSCO), São Paulo, Brazil., Silva MLG; Department of Directory, Brazilian Society of Radiation Oncology (BSRO), São Paulo, Brazil., Pinto FFE; Department of Directory, Brazilian Society of Orthopaedics and Traumatology (BSOT), São Paulo, Brazil., Costa FD; Department of Directory, Brazilian Society of Pathology (BSP), São Paulo, Brazil., Cequeira WS; AC Camargo Cancer Center, Department of Diagnosis and Imaging, São Paulo, Brazil., Munhoz RR; Department of Directory, Brazilian Society of Clinical Surgical (BSCO), São Paulo, Brazil., Mello CA; Department of Directory, Brazilian Society of Clinical Surgical (BSCO), São Paulo, Brazil., Schmerling RA; Department of Directory, Brazilian Society of Clinical Surgical (BSCO), São Paulo, Brazil., Filho WJD; Department of Directory, Brazilian Society of Clinical Surgical (BSCO), São Paulo, Brazil., Coelho TM; Department of Directory, Brazilian Society of Radiation Oncology (BSRO), São Paulo, Brazil., Ambrosio AVA; Department of Directory, Brazilian Society of Radiation Oncology (BSRO), São Paulo, Brazil., Leite ETT; Department of Directory, Brazilian Society of Radiation Oncology (BSRO), São Paulo, Brazil., Hanna SA; Department of Directory, Brazilian Society of Radiation Oncology (BSRO), São Paulo, Brazil., Nakagawa SA; Department of Directory, Brazilian Society of Orthopaedics and Traumatology (BSOT), São Paulo, Brazil., Baptista AM; Department of Directory, Brazilian Society of Orthopaedics and Traumatology (BSOT), São Paulo, Brazil., Pinheiro RN; Department of Directory, Brazilian Society of Surgical Oncology (BSSO), Rio de Janeiro, Brazil., de Oliveira JL; Department of Directory, Brazilian Society of Surgical Oncology (BSSO), Rio de Janeiro, Brazil., de Araújo MS; Department of Directory, Brazilian Society of Surgical Oncology (BSSO), Rio de Janeiro, Brazil., de Araujo RLC; Department of Directory, Brazilian Society of Surgical Oncology (BSSO), Rio de Janeiro, Brazil., Laporte GA; Department of Directory, Brazilian Society of Surgical Oncology (BSSO), Rio de Janeiro, Brazil., de Almeida Quadros C; Department of Directory, Brazilian Society of Surgical Oncology (BSSO), Rio de Janeiro, Brazil., de Oliveira AF; Department of Directory, Brazilian Society of Surgical Oncology (BSSO), Rio de Janeiro, Brazil., Lopes A; Department of Directory, Brazilian Society of Surgical Oncology (BSSO), Rio de Janeiro, Brazil. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of surgical oncology [J Surg Oncol] 2020 Apr; Vol. 121 (5), pp. 743-758. Date of Electronic Publication: 2020 Jan 22. |
DOI: | 10.1002/jso.25847 |
Abstrakt: | Introduction: Soft tissue sarcomas (STSs) are rare tumors and constitute only 1% of all tumors in adults. Indeed, due to their rarity, most cases in Brazil are not treated according to primary international guidelines. Methods: This consensus addresses the treatment of STSs in the extremities. It was made by workgroups from Brazilian Societies of Surgical Oncology, Orthopaedics, Clinical Oncology, Pathology, Radiology and Diagnostic Imaging, and Radiation Oncology. The workgroups based their arguments on the best level of evidence in the literature and recommendations were made according to diagnosis, staging, and treatment of STSs. A meeting was held with all the invited experts and the topics were presented individually with the definition of the degree of recommendation, based on the levels of evidence in the literature. Results: Risk factors and epidemiology were described as well as the pathological aspects and imaging. All recommendations are described with the degree of recommendation and levels of evidence. Conclusion: Recommendations based on the best literature regional aspects were made to guide professionals who treat STS. Separate consensus on specific treatments for retroperitoneal, visceral, trunk, head and neck sarcomas, and gastrointestinal stromal tumor, are not contemplated into this consensus. (© 2020 Wiley Periodicals, Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |